Back to MW MARSHALL WACE, LLP

ADVMADVM
Showing 6 of 18 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ADVERUM BIOTECHNOLOGIES INC

MARSHALL WACE, LLP previously held 0 shares of ADVM (ADVERUM BIOTECHNOLOGIES INC), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$301,137

Total Shares Change

-42,897

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$4.60
0
2025-Q3
Decreased
28,367
-42.8%
$128,5030.0%$4.60
0
2025-Q2
New
49,628
-
$106,7010.0%$2.32
30
2025-Q1
Exited
0
-100.0%
$00.0%$4.61
0
2024-Q4
Increased
98,027
+128.5%
$457,7870.0%$4.69
39
2024-Q3
Decreased
42,897
-79.0%
$301,1370.0%$6.94
0

Other major holders of ADVM: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used